4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-23-045450
Chief Development Officer sold 1,854 shares at $1.26 ($2,336)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy Chief Development Officer | 2023-08-28 | Sale | −1,854 | $1.26 | $2,336 | 325,290 | D |
| Open-market sales · 1,854 sh · avg $1.26 · $2,336 | |||||||
Loading xslF345X05/ownership.xml…